Anovulatorios. Fenómenos secundarios y riesgos

Francisco García Conti

Resumen


La contracepción oral combinada basada en la administración diaria de una tableta con una mezcla de un progestágeno con un estrógeno, desde el 5º hasta el 25° día del ciclo, fue introducida por Pincus y colaboradores hasta cerca de 16 años y, desde entonces, ha gozado de un amplio uso en la mayoría de los países en todo el mundo. 


Texto completo:

PDF

Referencias


ARBENZ, J. P. y WORMSER, P.: Schweize-rische medizinische Wochenschrift, 95, 1654, 1965. Cít. en Bol. Med. I.P.P.F., Die. 1970.

BAQUERO-ANGEL, J.: Comunicación personal, Nov. 1971. Depto. Med. Preventiva. Fac. Med. Univ. Jav. Bogotá, Colombia.

CARR, H.: Chromosomes after oral contraceptives. Lancet, 830, 1967.

CARRUTHERS, R.: Chloasma and oral contraceptives. Med. J. Australia 2, 17-20, July 2, 1966.

CATTERAL, R. D.: Candida Albicans and the contraceptive pill. Lancet. 2: 830-831, Oct. 15, 1966. Committee of safety of drugs: Brit. Med. J. 2.231, 1970.

DEFARES, J. G.: Influence of oral contraceptives on Women. Nederl. tijdschr. geneesk. Ill: 1115-1120, June 24, 1967. Cit. Year Book, of Endocr. 1970.

GARCIA-CONTI, F.: Usos ginecológicos de un nuevo progestágeno en microdosis: Norgestrel-d combinado con etinil-estradiol. Para ser publicado.

GOOLDEN, A. W. G., GARTSIDE, J. M., SANDERSON, C.: Thyroid status in pregnancy and in Women taking oral contraceptives. The Lancet, Jan. 7, 1967.

HALBERSTADT, E.: Medizinische Welt, 43, 806, 1968, Cit. en Bol. Med. IPPF, Die. 1970.

HALLER, J.: Ovulationshemmung durch hormone (Inhibición hormonal de la ovulación), 3. Auflaqe, Georq Thieme Verlaq, pp 139, Stuttgart, 1971.

HALLER, J.: Op. Cit.

INMAN, W. H. W. y VESSEY, M. P.: Investigatoin of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age. Brit. Med. J., 2: 193-199, April 27, 1968.

KINDT, W. G., HEINEN, G. y OERTEL, G. W.: Untersuchungen Uber das Verhalten der ACTH-reserve unter Verabreichung von Frauenneilkunde, 28, 1191, 1968 (Investigaciones sobre las fluctuaciones de las reservas de ACTH bajo administración de inhibidores de la ovulación).

KNORR y KNORR. Cit. por Haller, J. Op. Cit.

Laboratorios "LILLY". Carta al Cuerpo Médico, Bogotá, Col. 1970.

Laboratorios "UPJOHN" de Colombia. Depto. de propaganda médica. Comunicación personal. Nov. 1971.

LAURELL, C. B. et al : Internat. J. of Clin. Chem. 25, 294, 1969. Cit. en Bol. Med. IPPF, Die. 1970.

LEVAGH, J. H. et al: J.A.M.A. 201, 1967.

LOPEZ-ESCOBAR, G.: Comunicación personal. Oct. 1971. Asoc. Col. Fac. Med. División de Estudios de Población.

Medical Research Council: "Risg of Thromboembolic disease in women taking oral contraceptives: A preliminary communication to the Medical Research Council by a Subcommittee". Brit. Med. J., 2: 355-359, Mayo 6, 1967.

MORRIS, J., VAN WAGENEN, G.: Post-coital oral contraception. Internat. Planned Parethood Federation. Proceedings of the 8th. Internat. Conference, p. 256, London, 1967.

OSTERGAARD, E.: Oral anticonception. Side effects and riks. Acta Obstétrica et Gynecologica Scandinavica. Proceedings of the Symposium on Hormonal Treatment of Infertility and Oral Anticonception. Vol. XLVIII, Supplement 1, pp. 57-72, 1969.

PLATE, W. P.: Ovarian changes long-term oral contraception. Acta Endocrinológica, 55: 71-77, May, 1967.

Reports on Population/Family Planning. Population Council, New York, 1970.

RICE-WRAY, E.: Fertility after use of oral antifertility agents and health of children born to these mothers. Research of Steroids Vol. II, 525, 1966.

RICE-WRAY, E.: Chromosomes studies in children born to mothers who previously used hormonal contraceptives. Contraception, 1, 81, 1970.

Royal College of General Practitioners: "Oral contraception and thromboembolic d-i seases: A report by the Records Unit and Research Odvisory Service of the Royal College of General Practitioners". Journal of the Coll, of Gen. Praction. 13: 267-279, May, 1967.

Searle, G. D. (Sponsor). Proceedings of a Conference on Thromboembolic phenomena in women, Chicago, September 10, 1962.

SHAFEY, A. y SCHEINBERG, P.: Neurology, 16, 205, 1966.

SVOBODA, Z. y STERBA, R.: Metabolism: Clinical and Experimental, 1970.

SZONTAGH, F. E.: The role of the dose of progestogen, the ratio of progestogen to estrogen, and the dosage scheme on the mode of action, effectiveness and side-effects of oral contraceptives. Round table conference. Schveningen. The Netherlands, May 1966.

TAUSK, M.: Natural and Synthetic hormonal preparations. Nederl. tijdsch. geneesk. 1286-1290, July 22, 1967. Cit. en Year Book of Endocr. 1970.

TURNBULL, A. C. y KHOSLA, T.: Effect of oral contraceptives on glucose tolerance. Lancet. 1: 857-858, Apr. 26, 1969.

TYLER, E. T.: "The morning-after" pill. Fact and Fancy. Advances in Planned Parenthood. Vol. VI, 113, 1971. Proceedings of the 8th. Annual Meeting of the Am. Ass. of Planned Parenthood Physicians, Boston, Mass. April 9-10, 1970.

VESSEY, M. P. y DOLL, R.: Investigation of relation between use of oral contraceptives and Thromboembolic disease. Brit. Med. J. 2: 199-205, April 27, 1968.

VESSEY, M. P. y DOLL, R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Brit. Med. J., 2: 651-657, June 14, 1969.

VESSEY, M. P. et al: Op. Cit. (36).


comments powered by Disqus

Métricas de artículo

Cargando métricas ...

Metrics powered by PLOS ALM




Copyright (c) 2016 Revista Colombiana de Obstetricia y Ginecología

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

ISSN Impreso       0034-7434 

ISSN Electrónico   2463-0225

https://doi.org/10.18597/issn.0034-7434